Testing and Diagnosis: Solving the Puzzle of Missing Cilia
At a Glance
Familial nasal acilia is diagnosed by combining a patient’s history with nasal nitric oxide testing, microscopy of nasal cells, air-liquid interface culture, and genetic testing. No single result proves or rules out the condition, so specialists interpret all findings together.
Diagnosing nasal acilia (ciliary aplasia) is a complex process because there is no single “gold standard” test that provides a simple yes or no answer [1]. Instead, doctors must put together a puzzle using several different types of evidence to prove that your cilia are truly missing because of a genetic blueprint error, rather than just temporary damage [2][3].
The Screening Step: Nasal Nitric Oxide (nNO)
For most patients over the age of five, the first step is a nasal nitric oxide test. Nitric oxide is a gas naturally produced in healthy sinuses. In people with missing or non-functioning cilia, the levels of this gas are typically extremely low [3][4].
- The Threshold: A result below 77 nL/min is a strong screening clue in appropriately cooperative patients, not a stand-alone diagnosis. This cutoff depends on standardized technique, equipment, and an experienced laboratory. A normal result does not completely exclude every PCD-spectrum disorder [4][5].
- The Catch: Your levels can drop temporarily if you have a cold, a sinus infection, or even if your nose is very “stuffy” [6][7]. Because of this, a single low reading is not enough for a diagnosis. It should ideally be repeated on a separate day according to the testing center’s protocol [4][8].
Looking at the Tissue: Microscopy
If screening suggests a problem, the next step is a nasal brushing or biopsy. A tiny sample of the lining of your nose is taken and examined in two ways:
- High-Speed Video Microscopy (HSVM): Scientists use a specialized camera to record the cilia in slow motion. In cases of ciliary aplasia (also called RGMC), the technician will find that most cells simply have no “hairs” at all [2]. Any cilia that are present may actually move in a normal, healthy pattern—there just aren’t enough of them to clear mucus [2][9].
- Transmission Electron Microscopy (TEM): This is a powerful microscope that looks at the internal structure of a single cilium (the axoneme) [2]. In classic Primary Ciliary Dyskinesia (PCD), the cilia look “broken” inside. In RGMC, the few cilia that exist often look structurally perfect, which can lead to a confusing “normal” report if the pathologist isn’t looking for the number of cilia instead of their shape. Normal-looking remaining cilia or a normal TEM report do not by themselves exclude PCD [2][3].
Ruling Out Damage: Cell Culture (ALI)
One of the most common reasons a test shows “no cilia” is secondary damage from a past infection or environmental irritant [10]. To rule this out, specialized centers use Air-Liquid Interface (ALI) culture [11].
In this test, your nasal cells are grown in a lab for several weeks. In a controlled environment, away from pollution and germs, healthy cells will eventually sprout new, normal cilia. If the cells still fail to grow cilia in the lab, it supports the possibility that the problem is “primary” (built into your genetics) rather than “secondary” (caused by your environment). However, failure of cells to reciliate in ALI can also reflect technical culture problems, so it is supportive rather than absolute proof [10][11].
Genetic Testing
A definitive diagnosis of RGMC (Reduced Generation of Multiple Motile Cilia) is often supported by finding appropriate pathogenic or likely pathogenic variants in specific genes [12][3]. The two most common genes involved are:
- CCNO: Mutations here often cause a near-complete absence of cilia [13].
- MCIDAS: This gene is essential for the cell to build the “anchors” (basal bodies) that hold cilia in place [13][14].
A variant of uncertain significance (VUS) should not be treated as confirmation, and a negative panel does not strictly exclude the disease.
Completeness Checklist
Because these conditions are rare, ask your doctor whether these evaluations are appropriate for you:
- [ ] Clinical History: Does your history include chronic congestion or a daily wet cough since childhood? [15]
- [ ] Repeat nNO: Has repeat testing been considered if a result was unclear? [4]
- [ ] High-Speed Video: Did the lab quantify the number of cilia, or just check their movement? [2]
- [ ] Pathology Review: Does the report mention oligocilia (the presence of very few cilia)? [3]
- [ ] Genetic Panel: Did the testing include a comprehensive panel (including CCNO and MCIDAS)? [12]
- [ ] Follow-up: If tests were unclear, has a repeat sample or ALI culture been discussed? [10]
How to Read Your Report
If you see these terms on your pathology or microscopy report, here is what they generally mean:
- Aplasia/Acilia: No cilia were seen in the sample [2].
- Oligocilia: A significantly reduced number of cilia were found [3].
- Normal Ultrastructure: The cilia that were found look healthy inside. In the context of acilia, this can actually be a sign of RGMC [2][16].
- Secondary Changes: Evidence of inflammation or damage (like swelling or “blebbing”) which suggests the missing cilia might be due to a temporary cause like a recent cold [10].
Common questions in this guide
How is familial nasal acilia diagnosed?
What does a low nasal nitric oxide result mean?
Can normal-looking cilia rule out familial nasal acilia?
What is ALI cell culture used for?
What do acilia and oligocilia mean on a report?
Can CCNO or MCIDAS genetic testing confirm RGMC?
One line in your results can change your plan.
A low nasal nitric oxide reading should ideally be repeated on a separate day, per the testing center's protocol. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Familial nasal acilia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Primary Ciliary Dyskinesia: A Clinical Review.
Despotes KA, Zariwala MA, Davis SD, Ferkol TW
Cells 2024; (13(11)) doi:10.3390/cells13110974.
PMID: 38891105 - 2
Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.
Shapiro AJ, Leigh MW
Ultrastructural pathology 2017; (41(6)):373-385 doi:10.1080/01913123.2017.1362088.
PMID: 28915070 - 3
Novel CYCLIN-O pathogenic variants in a patient presenting with bronchiectasis secondary to reduced generation of multiple motile cilia.
Yap KH, Lim AYH, Thomas B, et al.
Respirology case reports 2024; (12(11)):e70057 doi:10.1002/rcr2.70057.
PMID: 39479223 - 4
Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols.
Shapiro AJ, Dell SD, Gaston B, et al.
Annals of the American Thoracic Society 2020; (17(2)):e1-e12 doi:10.1513/AnnalsATS.201904-347OT.
PMID: 31770003 - 5
Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure.
Raidt J, Krenz H, Tebbe J, et al.
Annals of the American Thoracic Society 2022; (19(8)):1275-1284 doi:10.1513/AnnalsATS.202106-728OC.
PMID: 35202559 - 6
Infant nasal nitric oxide over time: natural evolution and impact of respiratory tract infection.
Marthin JK, Philipsen MC, Rosthoj S, Nielsen KG
The European respiratory journal 2018; (51(6)) doi:10.1183/13993003.02503-2017.
PMID: 29748307 - 7
Role of Nasal Nitric Oxide in Primary Ciliary Dyskinesia and Other Respiratory Conditions in Children.
Paternò S, Pisani L, Zanconato S, et al.
International journal of molecular sciences 2023; (24(22)) doi:10.3390/ijms242216159.
PMID: 38003348 - 8
Nasal nitric oxide measurement for the diagnosis of primary ciliary dyskinesia: summary of the European Respiratory Society technical standard.
Marangu-Boore D, Lucas JS, Beydon N
Breathe (Sheffield, England) 2025; (21(2)):240230 doi:10.1183/20734735.0230-2024.
PMID: 40529313 - 9
Ciliary Beat Frequency and Pattern: An Accessible Tool for the Screening of Primary Ciliary Dyskinesia.
Kaspi E, Mazenq J, Pagin A, et al.
Diagnostics (Basel, Switzerland) 2026; (16(5)) doi:10.3390/diagnostics16050704.
PMID: 41827979 - 10
Secondary defects detected by transmission electron microscopy in primary ciliary dyskinesia diagnostics.
Dixon M, Shoemark A
Ultrastructural pathology 2017; (41(6)):390-398 doi:10.1080/01913123.2017.1365990.
PMID: 28922056 - 11
Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia.
Lee DDH, Cardinale D, Nigro E, et al.
The European respiratory journal 2021; (58(4)) doi:10.1183/13993003.00455-2020.
PMID: 33795320 - 12
Systematic Analysis of CCNO Variants in a Defined Population: Implications for Clinical Phenotype and Differential Diagnosis.
Amirav I, Wallmeier J, Loges NT, et al.
Human mutation 2016; (37(4)):396-405 doi:10.1002/humu.22957.
PMID: 26777464 - 13
Bi-allelic mutations in MCIDAS and CCNO cause human infertility associated with abnormal gamete transport.
Ma C, Wu H, Zhu D, et al.
Clinical genetics 2021; (100(6)):731-742 doi:10.1111/cge.14067.
PMID: 34569065 - 14
De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry.
Wallmeier J, Frank D, Shoemark A, et al.
American journal of human genetics 2019; (105(5)):1030-1039 doi:10.1016/j.ajhg.2019.09.022.
PMID: 31630787 - 15
Advances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review.
Dunsky K, Menezes M, Ferkol TW
JAMA otolaryngology-- head & neck surgery 2021; doi:10.1001/jamaoto.2021.0934.
PMID: 34137802 - 16
Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiation.
Khoury Damaa M, Serizay J, Balagué R, et al.
Cell reports 2025; (44(1)):115117 doi:10.1016/j.celrep.2024.115117.
PMID: 39740663
This page explains testing for familial nasal acilia for informational purposes only and does not constitute medical advice. Your treating specialist, pathologist, and genetics team should interpret your results and recommend next steps.